Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2013
10/08/2013US8551968 Methods for generation of antibodies
10/08/2013US8551951 Pharmaceutical preparations and methods for inhibiting tumors
10/08/2013US8551774 Expression vectors containing a truncated epstein barr nuclear antigen 1 lacking the Gly-Gly-Ala domain for enhanced transient gene expression
10/08/2013US8551773 Methods and compositions relating to improved lentiviral vectors and their applications
10/08/2013US8551772 Detection of mutations in a gene associated with resistance to viral infection, OAS1
10/08/2013US8551765 Solid support having electrostatic layer and use thereof
10/08/2013US8551755 Glucoamylase variants
10/08/2013US8551751 BX11 enzymes having xylosidase activity
10/08/2013US8551739 Modified vaccinia topoisomerase enzyme containing an affinity tag which is capable of facilitating purification of protein-DNA complexes away from unbound DNA; ligating duplex DNAs
10/08/2013US8551732 Increased production of a target product via stabilization of mRNA
10/08/2013US8551729 Mutants of Lactobacillus casei defective in carbon catabolism regulation
10/08/2013US8551715 Methods for identifying and isolating cells expressing a polypeptide
10/08/2013US8551705 Use of haploid genomes for genetic diagnosis, modification and multiplication
10/08/2013US8551699 PCA3, PCA3 genes, and methods of use
10/08/2013US8551693 Mutated voltage-gated sodium channel Nav alpha subunit for identification of modulators
10/08/2013US8551495 Anti-FMD vaccine composition and preparation and use thereof
10/08/2013US8551490 Genetic products differentially expressed in tumors and use thereof
10/08/2013US8551476 SP35 antibodies and uses thereof
10/08/2013US8551472 Method of making macrophage expressing an antibody directed against β-amyloid
10/08/2013CA2812264A1 Genetic testing for improved cattle fertility
10/08/2013CA2680799C Dominant gene suppression transgenes and methods of using same
10/08/2013CA2570114C Plasmid having three complete transcriptional units and immunogenic compositions for inducing an immune response to hiv
10/08/2013CA2554027C Biochip electroporator and its use in multi-site, single-cell electroporation
10/08/2013CA2547459C Modulators of nik-siva complex formation for treating immune disorders
10/08/2013CA2536492C Process for producing cytotoxic lymphocytes
10/08/2013CA2536471C Aav vectors for in vivo gene therapy of rheumatoid arthritis
10/08/2013CA2515200C Galacturonosyltransferases, nucleic acids encoding same and uses therefor
10/08/2013CA2512647C Method for manufacturing recombinant polyclonal proteins
10/08/2013CA2501939C Novel immunogenic proteins of leptospira
10/08/2013CA2482769C "doping" in walk-through mutagenesis
10/08/2013CA2349839C Ucp5
10/08/2013CA2238893C Il-13 receptor polypeptide
10/05/2013CA2811435A1 Amine compounds for the selective preparation of biological samples
10/03/2013WO2013149237A1 Targeting intracellular organelle zip codes with functional homing ligands from cell-internalizing phage combinatorial libraries
10/03/2013WO2013149167A1 Lentiviral vector particles having improved transduction efficiency for cells expressing dc- sign
10/03/2013WO2013149161A1 High molecular weight heparosan polymers and methods of production and use thereof
10/03/2013WO2013149141A1 Lipid-derived neutral nanoparticles
10/03/2013WO2013149091A1 Composition and method for treating neurodegenerative disease
10/03/2013WO2013149058A1 Monoclonal antibodies specific to human cav-1 and uses thereof
10/03/2013WO2013149018A1 Maize event dp-004114-3 and methods for detection thereof
10/03/2013WO2013149010A1 Enhanced antimicrobial lytic activity of a chimeric ply187 endolysin
10/03/2013WO2013148871A1 Engineered polypeptides
10/03/2013WO2013148867A1 Artificial sigma factors based on bisected t7 rna polymerase
10/03/2013WO2013148824A1 METHODS AND COMPOSITIONS TO TREAT CANCER USING BIFUNCTIONAL SRC-3 shRNA
10/03/2013WO2013148736A1 Compositions and treatments based on cadherin modulation
10/03/2013WO2013148559A1 Pathogen resistant plant cells and methods of making
10/03/2013WO2013148496A1 Rapid aneuploidy detection
10/03/2013WO2013148348A1 Engineered co2-fixing chemotrophic microorganisms producing carbon-based products and methods of using the same
10/03/2013WO2013148331A1 Charged nutritive fragments, proteins and methods
10/03/2013WO2013148330A1 Nutritive fragments, proteins and methods
10/03/2013WO2013148329A1 Charged nutritive proteins and methods
10/03/2013WO2013148328A1 Nutritive proteins and methods
10/03/2013WO2013148325A1 Nutritive fragments, proteins and methods
10/03/2013WO2013148321A1 Anti-sigmas for programmable transcriptional regulation
10/03/2013WO2013148302A1 Delivery of packaged rna to mammalian cells
10/03/2013WO2013148284A1 Antibodies that bind to a pcsk9 cleavage site and methods of use
10/03/2013WO2013148283A1 Compositions and methods for modulating tau expression for reducing seizure and modifying a neurodegenerative syndrome
10/03/2013WO2013148260A1 Methods for modulating tau expression for reducing seizure and modifying a neurodegenerative syndrome
10/03/2013WO2013148250A1 Tem-1 diagnostic antibodies
10/03/2013WO2013148224A1 Anti-tumor properties of dickkopf 3b
10/03/2013WO2013148214A1 Modulating disease through genetic engineering of plants
10/03/2013WO2013148201A1 Increased tuber set in potato
10/03/2013WO2013148198A1 Methods of treating cancer having an active wnt/beta - catenin pathway
10/03/2013WO2013148164A1 Computationally optimized broadly reactive antigens for h5n1 and h1n1 influenza viruses
10/03/2013WO2013148163A1 Genes encoding cellulase
10/03/2013WO2013148151A1 Plasma microribonucleic acids as biomarkers for endometriosis and endometriosis-associated ovarian cancer
10/03/2013WO2013148131A1 Transgenic plants having altered expression of pectin acetylesterase and methods of using same
10/03/2013WO2013148049A1 Recombinant cytotoxic t-lymphocyte-associated protein 4 (ctla4)
10/03/2013WO2013147899A1 Osteoprotegerin derived composition and use thereof
10/03/2013WO2013147606A1 Combinatorial gamma 9 delta 2 t cell receptor chain exchange
10/03/2013WO2013147425A1 Method for in vitro expansion of erythroid cells
10/03/2013WO2013147404A1 Use of dapg hydrolase gene as marker for screening transgenic plants
10/03/2013WO2013147352A1 Method using restriction fragment mass polymorphism to detect genetic mutation that causes hiv drug resistance
10/03/2013WO2013147320A1 MICROARRAY FOR DETECTION OF MUTATIONS IN β-GLOBIN GENES AND DETECTION METHOD THEREOF
10/03/2013WO2013147232A1 Bionanocapsule having antibody against surface protein of dendritic cell
10/03/2013WO2013147217A1 Sensor, detection method, detection system, and detection device
10/03/2013WO2013147213A1 Anti-siglec15 antibody with modified cdr
10/03/2013WO2013147212A1 Novel anti-siglec15 antibody
10/03/2013WO2013147208A1 Method for determining polynucleotide base sequence and device for determining polynucleotide base sequence
10/03/2013WO2013147206A1 Flavin-binding glucose dehydrogenase and polynucleotide encoding same
10/03/2013WO2013147176A1 Pharmaceutical composition for treatment and/or prevention of gall bladder cancer
10/03/2013WO2013147169A1 Pharmaceutical composition for treatment and/or prevention of liver cancer
10/03/2013WO2013147153A1 Anti-lamp5 antibody and utilization thereof
10/03/2013WO2013147140A1 Nucleic acid molecule capable of inhibiting expression of periostin gene, method for inhibiting expression of periostin gene, and use of said nucleic acid molecule
10/03/2013WO2013147082A1 Immortalized stem cells and medicinal composition and medicinal preparation comprising product thereof as active ingredient
10/03/2013WO2013146972A1 Method for regulating function of cell
10/03/2013WO2013146940A1 Modified leucine dehydrogenase
10/03/2013WO2013146738A1 Stem length associated marker derived from genome of wild sugarcane species, and use thereof
10/03/2013WO2013146695A1 Protein alignment method
10/03/2013WO2013146557A1 Biocatalysts for production of d-lactic acid from glycerol
10/03/2013WO2013146555A1 Method for producing steviol glycoside
10/03/2013WO2013146540A1 Method for producing ethanol
10/03/2013WO2013146480A1 Gene introduction method
10/03/2013WO2013146319A1 Diabetes-inducible bacterium
10/03/2013WO2013146171A1 Gene for shortening stalk of gramineous plant and method for producing short-stalked gramineous plant
10/03/2013WO2013145939A1 Method for detecting target substance, test kit, and detection equipment
10/03/2013WO2013145431A1 METHOD FOR AMPLIFYING cDNA DERIVED FROM TRACE AMOUNT OF SAMPLE
10/03/2013WO2013145331A1 Humanized mouse
10/03/2013WO2013145289A1 Lysophospholipid-containing cleaning agent
10/03/2013WO2013144685A1 Secretion of functional insulin glargine directly into the culture medium through over expression of kex2p intracellularly
1 ... 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 ... 4023